封面
市场调查报告书
商品编码
1538468

干细胞研究抗体市场报告:2030 年趋势、预测与竞争分析

Stem Cell Research Antibody Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

干细胞研究抗体的趋势和预测

2024年至2030年,全球干细胞研究抗体市场预计将以5.2%的复合年增长率成长。该市场的主要驱动力是对干细胞研究日益增长的兴趣和投资、单株抗体生产、重组抗体生产和高通量筛检方法等抗体生产技术的持续进步,以及政府的资助倡议和支持。津贴进行干细胞研究计划。全球干细胞研究抗体市场的未来前景广阔,製药和生物技术、CRO 和 CDMO 以及学术和研究机构市场充满机会。

分段干细胞研究抗体

该研究包括按类型、应用和地区分類的全球干细胞研究抗体的预测。

干细胞研究抗体市场洞察

Lucintel 表示,预计神经元在预测期内将经历最高的增长。

在这个市场中,药品和生物技术预计将经历最高的成长。

预计北美地区在预测期内将出现最高的成长。

常问问题

Q1.市场成长预测是多少:

A1. 2024年至2030年,全球干细胞研究抗体市场预计将以5.2%的复合年增长率成长。

Q2. 影响市场成长的关键驱动因素是:

A2. 该市场的主要驱动力是对干细胞研究的兴趣和投资的增加,单株抗体生产、重组抗体生产和高通量筛检方法等抗体生产技术的持续进步,以及政府的资助倡议和对干细胞的津贴。

Q3.市场的主要细分市场是:

A3. 全球干细胞研究抗体市场的未来对于製药和生物技术公司、CRO和CDMO以及学术和研究机构市场来说是充满希望的。

Q4.市场的主要企业是:

A4. 生产干细胞研究抗体的主要企业如下:

  • Thermo Fisher Scientific
  • Merck
  • Abcam
  • Cell Signaling Technology
  • R&D Systems
  • BD Biosciences
  • BioLegend
  • Bio-Rad Antibodies
  • GeneTex
  • Novus Biologicals

Q5.未来最大的细分市场是什么?

A5.Lucintel 预测神经元在预测期内将经历最高的成长。

Q6.未来五年预计哪些地区的市场成长最大?

A6. 预计北美地区在预测期内将出现最高成长。

Q7. 可以客製化报告吗?

A7。

目录

第一章执行摘要

第二章全球干细胞研究抗体市场:市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势(2018-2023)与预测(2024-2030)
  • 全球干细胞研究抗体市场趋势(2018-2023)与预测(2024-2030)
  • 全球干细胞研究抗体市场(按类型)
    • 神经细胞
    • 造血细胞
    • 间质细胞
    • 内皮细胞
  • 全球干细胞研究抗体市场(依应用)
    • 製药和生物技术公司
    • CRO・CDMO
    • 学术/研究机构
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 按地区分類的全球干细胞研究抗体市场
  • 北美干细胞研究抗体市场
  • 欧洲干细胞研究抗体市场
  • 亚太地区干细胞研究抗体市场
  • 其他区域干细胞研究抗体市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球干细胞研究抗体市场的成长机会(按类型)
    • 全球干细胞研究抗体市场应用的成长机会
    • 全球干细胞研究抗体市场成长机会(按地区)
  • 全球干细胞研究抗体市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球干细胞研究抗体市场产能
    • 全球干细胞研究抗体市场的合併、收购与合资企业
    • 认证和许可

第七章主要企业概况

  • Thermo Fisher Scientific
  • Merck
  • Abcam
  • Cell Signaling Technology
  • R&D Systems
  • BD Biosciences
  • BioLegend
  • Bio-Rad Antibodies
  • GeneTex
  • Novus Biologicals
简介目录

Stem Cell Research Antibody Trends and Forecast

The future of the global stem cell research antibody market looks promising with opportunities in the pharmaceutical & biotechnology company, CRO & CDMO, and academic & research institute markets. The global stem cell research antibody market is expected to grow with a CAGR of 5.2% from 2024 to 2030. The major drivers for this market are increasing interest and investment in stem cell research, ongoing advancements in antibody production technologies, such as monoclonal antibody production, recombinant antibody engineering, and high-throughput screening methods, as well as, government funding initiatives and research grants support stem cell research projects.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Stem Cell Research Antibody by Segment

The study includes a forecast for the global stem cell research antibody by type, application, and region.

Stem Cell Research Antibody Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Neural
  • Hematopoietic
  • Mesenchymal
  • Endothelial

Stem Cell Research Antibody Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Pharmaceutical & Biotechnology Companies
  • CRO & CDMO
  • Academic & Research Institutes
  • Others

Stem Cell Research Antibody Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Stem Cell Research Antibody Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies stem cell research antibody companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the stem cell research antibody companies profiled in this report include-

  • Thermo Fisher Scientific
  • Merck
  • Abcam
  • Cell Signaling Technology
  • R&D Systems
  • BD Biosciences
  • BioLegend
  • Bio-Rad Antibodies
  • GeneTex
  • Novus Biologicals

Stem Cell Research Antibody Market Insights

Lucintel forecasts that neural is expected to witness the highest growth over the forecast period.

Within this market, pharmaceutical & biotechnology is expected to witness the highest growth.

North America is expected to witness the highest growth over the forecast period.

Features of the Global Stem Cell Research Antibody Market

Market Size Estimates: Stem cell research antibody market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Stem cell research antibody market size by type, application, and region in terms of value ($B).

Regional Analysis: Stem cell research antibody market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the stem cell research antibody market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the stem cell research antibody market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for stem cell research antibody market?

Answer: The global stem cell research antibody market is expected to grow with a CAGR of 5.2% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the stem cell research antibody market?

Answer: The major drivers for this market are increasing interest and investment in stem cell research, ongoing advancements in antibody production technologies, such as monoclonal antibody production, recombinant antibody engineering, and high-throughput screening methods, as well as, government funding initiatives and research grants support stem cell research projects.

Q3. What are the major segments for stem cell research antibody market?

Answer: The future of the global stem cell research antibody market looks promising with opportunities in the pharmaceutical & biotechnology company, CRO & CDMO, and academic & research institute markets.

Q4. Who are the key stem cell research antibody market companies?

Answer: Some of the key stem cell research antibody companies are as follows:

  • Thermo Fisher Scientific
  • Merck
  • Abcam
  • Cell Signaling Technology
  • R&D Systems
  • BD Biosciences
  • BioLegend
  • Bio-Rad Antibodies
  • GeneTex
  • Novus Biologicals

Q5. Which stem cell research antibody market segment will be the largest in future?

Answer: Lucintel forecasts that neural is expected to witness the highest growth over the forecast period.

Q6. In stem cell research antibody market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness the highest growth over the forecast period.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the stem cell research antibody market by type (neural, hematopoietic, mesenchymal, and endothelial), application (pharmaceutical & biotechnology companies, CRO & CDMO, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Stem Cell Research Antibody Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Stem Cell Research Antibody Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Stem Cell Research Antibody Market by Type
    • 3.3.1: Neural
    • 3.3.2: Hematopoietic
    • 3.3.3: Mesenchymal
    • 3.3.4: Endothelial
  • 3.4: Global Stem Cell Research Antibody Market by Application
    • 3.4.1: Pharmaceutical & Biotechnology Companies
    • 3.4.2: CRO & CDMO
    • 3.4.3: Academic & Research Institutes
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Stem Cell Research Antibody Market by Region
  • 4.2: North American Stem Cell Research Antibody Market
    • 4.2.1: North American Stem Cell Research Antibody Market by Type: Neural, Hematopoietic, Mesenchymal, and Endothelial
    • 4.2.2: North American Stem Cell Research Antibody Market by Application: Pharmaceutical & Biotechnology Companies, CRO & CDMO, Academic & Research Institutes, and Others
  • 4.3: European Stem Cell Research Antibody Market
    • 4.3.1: European Stem Cell Research Antibody Market by Type: Neural, Hematopoietic, Mesenchymal, and Endothelial
    • 4.3.2: European Stem Cell Research Antibody Market by Application: Pharmaceutical & Biotechnology Companies, CRO & CDMO, Academic & Research Institutes, and Others
  • 4.4: APAC Stem Cell Research Antibody Market
    • 4.4.1: APAC Stem Cell Research Antibody Market by Type: Neural, Hematopoietic, Mesenchymal, and Endothelial
    • 4.4.2: APAC Stem Cell Research Antibody Market by Application: Pharmaceutical & Biotechnology Companies, CRO & CDMO, Academic & Research Institutes, and Others
  • 4.5: ROW Stem Cell Research Antibody Market
    • 4.5.1: ROW Stem Cell Research Antibody Market by Type: Neural, Hematopoietic, Mesenchymal, and Endothelial
    • 4.5.2: ROW Stem Cell Research Antibody Market by Application: Pharmaceutical & Biotechnology Companies, CRO & CDMO, Academic & Research Institutes, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Stem Cell Research Antibody Market by Type
    • 6.1.2: Growth Opportunities for the Global Stem Cell Research Antibody Market by Application
    • 6.1.3: Growth Opportunities for the Global Stem Cell Research Antibody Market by Region
  • 6.2: Emerging Trends in the Global Stem Cell Research Antibody Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Stem Cell Research Antibody Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Stem Cell Research Antibody Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Merck
  • 7.3: Abcam
  • 7.4: Cell Signaling Technology
  • 7.5: R&D Systems
  • 7.6: BD Biosciences
  • 7.7: BioLegend
  • 7.8: Bio-Rad Antibodies
  • 7.9: GeneTex
  • 7.10: Novus Biologicals